Quick answer: Medicare Part D 2026 delivers real relief. The Inflation Reduction Act introduced a firm annual out-of-pocket cap in Part D: $2,000 in 2025, rising with inflation to $2,100 in 2026. Once you hit it, your plan pays 100% of covered drugs for the rest of the year. It’s real relief, but the cap only applies to Part D-covered drugs, and that’s where the gaps are.
Medicare Part D 2026 brings the biggest Part D change in a generation. This article explains it clearly and honestly, and does what most coverage doesn’t: it maps the gaps that still leave many specialty-drug patients paying.
How the Medicare Part D 2026 cap works now that the “donut hole” is gone
The old “donut hole” coverage gap is gone. Now there’s a clear out-of-pocket cap: once your out-of-pocket spending on covered drugs reaches the annual limit, you pay nothing more for those drugs for the rest of the year.
The three remaining coverage phases
The simplified design keeps three phases: the deductible, an initial coverage phase with coinsurance, and the catastrophic phase, in which, after the cap, the plan covers 100% of covered drugs.
The Medicare Prescription Payment Plan (spreading costs across the year)
The Medicare Prescription Payment Plan is an option that lets you spread your out-of-pocket spending into monthly installments across the year, instead of paying a lot at once early on.
Good relief isn’t the same as full protection: it pays to know exactly what’s left out.
What the cap does NOT cover
The Medicare Part D 2026 cap is powerful, but it has clear boundaries. Here is what it does not count toward your limit.
Part B drugs: clinician-administered infusions and injectables
The cap applies to Part D. It does not cover clinician-administered infusions and injectables billed under Part B, the category many specialty biologics fall into. This is the most important gap for high-cost patients.
Non-covered drugs and drugs bought outside your plan
The cap only counts drugs your plan covers. Drugs your plan doesn’t cover, or ones you buy outside it, don’t count toward the limit.
Why manufacturer coupons don’t count toward the cap
In Medicare, manufacturer copay coupons don’t count toward reaching the cap. Only your real out-of-pocket spending counts, important when planning your year.
Who still faces high specialty drug costs
Even with Medicare Part D 2026 in place, several groups still face high specialty-drug bills.
Commercially and under-insured patients
The cap is a Medicare feature. Those with commercial insurance or who are underinsured don’t benefit from this limit and may still face high costs.
Patients stuck in prior authorization denials
If your drug is blocked by a prior authorization denial, the cap doesn’t help until the medication is covered. That’s why the two topics go hand in hand.
Drug price negotiation: what changes in 2026
Another piece of the reform: the first round of Medicare price negotiation takes effect in 2026 for an initial group of drugs. It’s a structural change whose effect will unfold over time.
Planning around the gaps: where cross-border access still fits
For the gaps the cap doesn’t cover (Part B drugs, non-covered drugs, or commercial cases), safe, licensed cross-border access, for those with a valid prescription, still has a role. Without ever overstating it: it’s one option among several, not a universal solution.
Final thoughts
The Medicare Part D 2026 cap is genuinely good news, but it doesn’t fully protect everyone. If you fall into one of the gaps, we can help you understand your options clearly and without pressure.
Figures (annual cap, phases) reflect information available in mid-2026 and may be updated; always verify current values with Medicare before making decisions.
Notice. This article is informational and does not constitute medical, legal or financial advice. We do not prescribe, sell, or dispense medications. Check your coverage details with Medicare or your plan.
Sources
- Centers for Medicare & Medicaid Services: Final CY 2026 Part D redesign program instructions.
- Medicare.gov: How much does Medicare drug coverage cost?
